Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hemant Surgical IndustriesBOM:543916 -0.87%80 Interest Coverage is 7.34 as of Mar. 2026, which is 64% above its 10-year median of 4.47. GuruFocus rates BOM:543916 with a GF Score™ of 80/100 and a GF Value™ of ₹332.62 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 464 Medical Devices & Instruments companies, Hemant Surgical Industries ranks worse than 74.35% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Hemant Surgical Industries's
Operating Income
for the
six
months ended in Mar. 2026 was ₹148 Mil. Hemant Surgical Industries's Interest Expense for the
six
months ended in Mar. 2026 was ₹-20 Mil.
Hemant Surgical Industries's interest coverage for the quarter that ended in Mar. 2026 was 7.34.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Hemant Surgical Industries's Interest Coverage or its related term are showing as below:
BOM:543916'
s Interest Coverage Range Over the Past 10 Years
Min: 1.39 Med: 4.47 Max: 10.12
Current: 5.47
BOM:543916's Interest Coverage is ranked worse than 74.35% of 464
companies
in the Medical Devices & Instruments industry
Industry Median: 16.08
vs BOM:543916: 5.47
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Hemant Surgical Industries Interest Coverage Related Terms
Hemant Surgical Industries Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BOM:543916 vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Hemant Surgical Industries's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hemant Surgical Industries Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hemant Surgical Industries's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Hemant Surgical Industries's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hemant Surgical Industries (BOM:543916) has a Interest Coverage of 7.34 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Hemant Surgical Industries and its competitors. This is 64% above median its historical median of 4.47. Over the past decade, Hemant Surgical Industries' Interest Coverage has ranged from 1.39 to 10.12. According to the industry distribution chart, Hemant Surgical Industries ranks #345 out of 464 companies in the Medical Devices & Instruments industry, placing it in the top 74.4%.
Is Hemant Surgical Industries' Interest Coverage too high?
Hemant Surgical Industries' current Interest Coverage of 7.34 is 64% above median its 10-year median of 4.47. Over the past 10 years, this metric has ranged from a low of 1.39 to a high of 10.12. The Medical Devices & Instruments industry median Interest Coverage is 16.08. Hemant Surgical Industries' value of 7.34 is 54.4% below this industry median. Based on the distribution chart, Hemant Surgical Industries ranks #345 out of 464 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Hemant Surgical Industries has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hemant Surgical Industries' Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Hemant Surgical Industries ranks #345 out of 464 companies for Interest Coverage. This places Hemant Surgical Industries in the lower half of its industry. The industry median Interest Coverage is 16.08. Hemant Surgical Industries' value of 7.34 is 54.4% below this benchmark. Historically, Hemant Surgical Industries' own Interest Coverage has ranged from 1.39 to 10.12 over the past decade. While the company's 10-year median is 4.47 vs. the industry median of 16.08, Hemant Surgical Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.08, based on 464 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hemant Surgical Industries's current Interest Coverage of 7.34 is 54.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Hemant Surgical Industries and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hemant Surgical Industries's current Interest Coverage is 7.34, which is 64% above median its own 10-year median of 4.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemant Surgical Industries stock overvalued right now?
Based on GuruFocus' analysis, Hemant Surgical Industries (BOM:543916) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹332.62, compared to a current price of ₹380.90 — trading 14.5% above its estimated fair value. The current Interest Coverage is 7.34, which is 64% above median its 10-year median of 4.47 and 54.4% below the Medical Devices & Instruments industry median of 16.08. Hemant Surgical Industries' overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Hemant Surgical Industries (BOM:543916), the current Interest Coverage is 7.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hemant Surgical Industries (BOM:543916) Overvalued in 2026?
Based on GuruFocus' analysis, Hemant Surgical Industries stock appears to be overvalued.
The current stock price of ₹380.90 is trading 14.5% above its estimated GF Value™ of ₹332.62.
GuruFocus considers Hemant Surgical Industries to be Modestly Overvalued.
Key valuation signals for BOM:543916:
Interest Coverage: 7.34 (64% above median its 10-year median of 4.47)
GF Value™: ₹332.62 vs. price of ₹380.90 (14.5% above fair value)
Industry Position: 54.4% below the Medical Devices & Instruments median (#345 of 464)
No single metric tells the full story. See the BOM:543916 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hemant Surgical Industries Ltd is engaged in Importing, manufacturing, and marketing quality surgical and Pharmaceutical Products at an economical price. Its product offerings cover a wide spectrum of equipment and disposables required for (i) Renal Care, (ii) Cardiovascular Disease, (iii) Respiratory Disease, (iv) Critical Care and Radiology, and (v) Surgical disposables. Its products include JMS Meditape, JMS Infusion Set, JMS Scalp Vein Set, Ventilators, ECG Machines, and others.
80GF Score
Get the complete analysis for BOM:543916
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543916 has been successfully added to your 
